IMVT in the 13F filings
Immunovant Inc · CUSIP 45258J102
- Quarter end
- 31 Mar 2024
- the date the book describes
- Filed
- 24 May 2024
- latest of these filings; the earliest 14 May 2024
- Managers listing it
- 4
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q4 2023 and Q1 2024; 3 listed it in both
- Shares listed
- 5,458,723
- combined, among listed positions
- Reported value
- $176m
- combined, at the quarter end
Among the 93 comparable managers: 2 buyers (opened or added shares) and 3 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +584,337.
Managers listing IMVT in Q1 2024
4 of 4 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Viking Global Investors LP | 1,809,172 | $58m | 0.22% | New | new | 15 May 2024 (the filing on sec.gov) |
| Point72 Asset Management LP | 1,383,810 | $45m | 0.11% | Trimmed | -1,283,073 | 15 May 2024 (the filing on sec.gov) |
| Woodline Partners LP | 1,289,504 | $42m | 0.38% | Added | +539,238 | 15 May 2024 (the filing on sec.gov) |
| Capital Research Global Investors | 976,237 | $32m | under 0.1% | Held | 0 | 14 May 2024 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Viking Global Investors LPnew position · 1,809,172 shares now+1,809,172
- Woodline Partners LPexisting position · 1,289,504 shares now+539,238
Reductions
- Point72 Asset Management LPexisting position · 1,383,810 shares now-1,283,073
New positions and exits
New (1)
Exited (2)
- Farallon Capital Management LLCwas $14m
- Soros Fund Management LLCwas $5.9m
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q4 2019 | 2 | $5.7m | n.a. | n.a. |
| Q1 2020 | 1 | $5.1m | n.a. | n.a. |
| Q2 2020 | 1 | $5.6m | n.a. | n.a. |
| Q3 2020 | 3 | $60m | n.a. | n.a. |
| Q4 2020 | 3 | $34m | n.a. | n.a. |
| Q1 2021 | 3 | $22m | n.a. | n.a. |
| Q2 2021 | 2 | $41m | n.a. | n.a. |
| Q3 2021 | 1 | $2.1m | n.a. | n.a. |
| Q4 2021 | 1 | $930k | n.a. | n.a. |
| Q1 2022 | 1 | $745k | n.a. | n.a. |
| Q3 2022 | 2 | $21m | n.a. | n.a. |
| Q4 2022 | 2 | $24m | n.a. | n.a. |
| Q1 2023 | 3 | $30m | n.a. | n.a. |
| Q2 2023 | 3 | $49m | n.a. | n.a. |
| Q3 2023 | 5 | $111m | n.a. | n.a. |
| Q4 2023 | 5 | $205m | 3 | 2 |
| Q1 2024 | 4 | $176m | 2 | 3 |
| Q2 2024 | 5 | $136m | 4 | 0 |
| Q3 2024 | 4 | $135m | 0 | 1 |
| Q4 2024 | 3 | $51m | 0 | 3 |
| Q1 2025 | 3 | $45m | 1 | 1 |
| Q2 2025 | 4 | $81m | 3 | 1 |
| Q3 2025 | 3 | $80m | 1 | 0 |
| Q4 2025 | 3 | $101m | 11 | 12 |
| Q1 2026 | 3 | $90m | 12 | 9 |
| Q2 2026 | 4 | $927m | 15 | 8 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IMVT and GILD →IMVT and AMGN →IMVT and ARGX →Choose a stock to compare with IMVT →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IMVT, latest filings →Back to the 13F Explorer →